title: Natriuretic peptides levels are related to HDL-cholesterol with no influence on endothelium dependent vasodilatation.
abstract: BACKGROUND
  The natriuretic peptides, Brain Natriuretic Peptide (BNP), C-type Natriuretic Peptide (CNP), are mediators of cardiovascular homeostasis. The impairment of arterial ability to vasodilate, also known as endothelial dysfunction, represents the first stage of atherosclerotic damage and may be assessed as brachial flow mediated vasodilation (FMV) in human. Generally an altered brachial FMV is documented in association to several cardiovascular risk factors as hypercholesterolemia. Aim of the study was to evaluate the behaviour of BNP and CNP in hyperlipemia and the potential relationship to FMV.
  
  
  METHODS
  Forty-four hyperlipemic patients (LDL-cholesterol > 130 mg/dl and/or triglycerides > 150, age 35-60 y) of both genders and 20 normolipemic patients, matched for age and sex were investigated.
  
  
  RESULTS
  Patients had lower values of brachial FMV in comparison to controls (3.9 +/- 3.5 vs 7.5 +/- 0.5%, p < 0.005), no differences were observed in BNP (4.6 +/- 4.6 vs 5.9 +/- 3.4 ng/mL, p = n.s) and CNP (4.1 +/- 5.8 vs 5.7 +/- 3.3 ng/mL, p = n.s). Univariate analysis showed a positive correlation between BNP and HDL-cholesterol values (r = 0.36, p = 0.001). In the multivariate analysis, LDL-cholesterol (beta = -0.57), HDL-cholesterol (beta = 0.26) and brachial artery diameter (beta = -0.33) were predictors of brachial FMV. The only predictive variable for CNP was HDL-cholesterol (beta = 0.37).
  
  
  CONCLUSIONS
  The present study suggested that natriuretic peptides, BNP and CNP, are not altered in patients affected by hypercholesterolemia. Nevertheless, the levels of HDL-cholesterol are strictly related to the values of CNP. This observation, in humans, adds another mechanism to the vascular control exerted by HDL.
authors.affiliation: Internal Medicine Angiology and Atherosclerosis Disease, University of Perugia, Italy. glupa@unipg.it
authors.forename: G
authors.initials: G
authors.lastname: Lupattelli
authors.forename: S
authors.initials: S
authors.lastname: Marchesi
authors.forename: D
authors.initials: D
authors.lastname: Siepi
authors.forename: F
authors.initials: F
authors.lastname: Bagaglia
authors.forename: B
authors.initials: B
authors.lastname: Palumbo
authors.forename: A R
authors.initials: AR
authors.lastname: Roscini
authors.forename: G
authors.initials: G
authors.lastname: Schillaci
authors.forename: G
authors.initials: G
authors.lastname: Vaudo
authors.forename: H
authors.initials: H
authors.lastname: Sinzinger
authors.forename: E
authors.initials: E
authors.lastname: Mannarino
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000097:blood*; D001783:Blood Flow Velocity / Q000502:physiology; D001916:Brachial Artery / Q000503:physiopathology; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D020098:Natriuretic Peptide, C-Type / Q000097:blood*; D012307:Risk Factors; D013223:Statistics as Topic; D014280:Triglycerides / Q000097:blood; D014664:Vasodilation / Q000502:physiology*
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D020097:Natriuretic Peptide, Brain; D020098:Natriuretic Peptide, C-Type